Skip to content

Clinical trials

Phase 2 Coronary Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 2 Country / region: United States Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20031
20041
20053
20063
20071
20083
20101
20111
20123
20141
20162
20171
20181
20202
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated2
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)7
Hoffmann-La Roche4
National Center for Complementary and Integrative Health (NCCIH)2
Novartis Pharmaceuticals2
Sanofi2
ARCA Biopharma, Inc.1
Abbott Medical Devices1
AstraZeneca1
Boehringer Ingelheim1
Critical Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease39
Coronary Artery Disease14
Myocardial Ischemia8
Heart Diseases7
Cardiovascular Diseases5
Acute Coronary Syndrome4
Atherosclerosis4
Myocardial Infarction4
Vascular Diseases4
Arterial Occlusive Diseases3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.